Healthcare -
Biotechnology - NASDAQ - US
$ 3.76
-0.529 %
$ 336 M
Market Cap
-8.55
P/E
TRVI - TOTAL LIABILITIES
Total Liabilities TRVI - Trevi Therapeutics, Inc.
6.86 M
LAST VALUE
-43.40%
2 YEAR CAGR
16.59%
5 YEAR CAGR
0.00%
10 YEAR CAGR